CRYOPORT INC | TalkMarkets | Page 1
No data available
No data available

People who follow this stock (34)

Latest Posts

About This Stock More About This Stock
Check Your Portfolio For Small Cap Weighting: Growth, Innovation Or Speculation?
Article By: Rod Raynovich
Monday, August 15, 2022 5:12 AM EDT
The SPDR S&P Biotech ETF remains our key indicator for small cap biotechs. It is up 14.55% over one month at $93.78 but is still down 16% YTD. The Russell 2000 is up 16.5% over one month mirroring biotech small cap performance.
In this article: CYRX, QDEL, IWM, XBI, CCXI, EVH, ARKG, MRTX
Read
Mid-Cap Biotech Picks: Seasonal Rally Underway
Article By: Rod Raynovich
Saturday, July 3, 2021 6:54 PM EDT
Many Mid-Cap biotech stocks were hit hard after the February peak. We suggest three new mid-cap biotech picks. All three picks can be volatile but very tradable.
In this article: CYRX, CRSP, VCYT Also: ARKG, XBI
Read
64 Biggest Movers From Yesterday
Article By: Benzinga
Thursday, August 27, 2020 5:04 AM EDT
Here are the best gainers and losers moving in pre-market.
In this article: DKS, EXPR, LRN, RIG, AMTX, FARM, CRM, DY, JWN, NIO, VHI, CHCI, GEVO, KIRK, BKYI, FLDM, INOD, CYRX, IMBI, VNET, BGFV, PEIX, ADBE, HIBB, KELYB, URBN, PPSI, NFLX, CAAS, CNSP, GOGO, WORX, WDAY, VJET, HPE, NAKD, ALT, PLAN, XSPA, TRUP, PSTG, OCUL, ANY, LPCN, CWBR, BIGC, EVSI, FLNT, MICT, GTX, IMUX, SWBI, SONN, BRQS, ORTX, UONE, BLI, RUHN, AYRO, EDNT, KROS, LI, OCGN, DNK
Read
IBI Market Insight: To Profit From Value Disconnect
Article By: Dr. Hung Tran
Wednesday, October 30, 2019 2:11 PM EDT
Precision medicine therapeutics and companion diagnostics are powering the next wave of innovation.
In this article: RGNX, CYRX, GLPG
Read
Update On Currently Recommended Stocks
Article By: SmithOnStocks
Monday, September 25, 2017 4:19 PM EDT
In this report I update my objectives and include several buy recommendations in the biotech sphere.
In this article: CYTK, AIS, NWBO, PTLA, RGEN, CYRX, BMY, ALIM, AGEN, EYPT, AMAG, WINT, AMGN, GNE, BIIB
Read

Latest Tweets for $CYRX

No tweets yet!

PARTNER HEADLINES